M. Bala Sundaram, A. Dhanesh Gandhi, T.N. Bhaskaran, P. Kavitha, T. Navukkarasi, R. Babujanarthanam
M. Bala Sundaram1, A. Dhanesh Gandhi1, T.N. Bhaskaran1, P. Kavitha2, T. Navukkarasi3, R. Babujanarthanam1*
1Nano and Energy Biosciences Laboratory, Department of Biotechnology, Thiruvalluvar University, Serkkadu, Vellore.
2Department of Biochemistry, KMG College of Arts and Science, Gudiyattam, Vellore.
3Diabetic Counsellor and Nutritionist, Smart Nutri Care, Madurai.
1Associate Professor, Department of Biotechnology, Thiruvalluvar University, Serkkadu, Vellore.
Volume - 13,
Issue - 10,
Year - 2020
No wonder diabetes is a “Silent Killer” and 8th leading cause of death in the industrialized world. It is a chronic disorder of carbohydrate metabolism, characterized by hyperglycaemia and glycosuria produced by an absolute or relative insufficiency of Insulin, associated with disturbance of fat and protein metabolism. To put an end to this dreadful disease seems to be a painstaking task. Many of the synthetic hypoglycaemic drugs can produce serious side effects including haematological, luteneous and gastrointestinal reactions and disturbances of liver and kidney, besides certain oral hypoglycaemic agents are not effective in lowering the blood sugar in chronic diabetic patients. Therefore in the last two decades, there has been considerable emphasis on development of drugs from medicinal plants. A large number of plant and mineral compounds have been mentioned in the ancient treatises of siddha, ayurvedic and Tibbi medicine as valuable in the treatment of diabetes mellitus. The Momordica charantia has been extensively studied in various aspects, but a meagre work has been done in assessing its anti-hyperglycaemic activity of its various parts such as leaves, fruits and seeds that are commonly and widely used for the edible purpose by the large number of population, because it possess blood glucose lowering effect. The ethanolic extract of the plant were treated for the diabetes induced albino rats of wistar strain. The results of the body weight, serum glucose, lipid profile and antioxidant enzymes were recovered in the treated rats than the diabetic group. Histopathology of pancreas, liver and kidney reveals that regeneration of the damaged tissue was observed. Therefore the experiment proves that seed extract of Momordica charantia has the more anti-diabetic activity.
Cite this article:
M. Bala Sundaram, A. Dhanesh Gandhi, T.N. Bhaskaran, P. Kavitha, T. Navukkarasi, R. Babujanarthanam. In vivo Hypoglycaemic effect of Ethanolic extract of Momordica charantia using Albino rats of Wistar strain. Research J. Pharm. and Tech. 2020; 13(10):4875-4882. doi: 10.5958/0974-360X.2020.00858.6
M. Bala Sundaram, A. Dhanesh Gandhi, T.N. Bhaskaran, P. Kavitha, T. Navukkarasi, R. Babujanarthanam. In vivo Hypoglycaemic effect of Ethanolic extract of Momordica charantia using Albino rats of Wistar strain. Research J. Pharm. and Tech. 2020; 13(10):4875-4882. doi: 10.5958/0974-360X.2020.00858.6 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-10-61
1. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia. Diabetes care. 2007; 30(1):113-119.
2. Rao US. Phenyl Propanoid Glycoside, An Eleutheroside derivative in the Regulation Carbohydrate Metabolism in Hepatic Tissues in T2DM experimental Rats. Research Journal of Pharmacy and Technology. 2019;12(1):283-290.
3. Beardsall K, Diderholm BM, Dunger DB. Insulin and carbohydrate metabolism. Best Practice and Research Clinical Endocrinology and Metabolism. 2008; 22(1):41-55.
4. Spiller HA, Sawyer TS. Toxicology of oral antidiabetic medications. American journal of health-system pharmacy. 2006; 63(10):929-938.
5. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care. 2009; 32(1):193-203.
6. Vijayaraj R, Kumar KN, Mani P, Senthil J, Jayaseelan T, Kumar GD. Hypoglycaemic and antioxidant activity of Achyranthes aspera seed extract and its effect on streptozotocin induced diabetic rats. Int J Biol Pharm Res. 2016; 7:23-28.
7. Rao US, Zin T, Subramaniam SA, Shan TB, Mogan KA, Ismail AS. Cross-Sectional Study on Knowledge, Attitude and Practice regarding Diabetes mellitus among Medical and Non-Medical Students. Research Journal of Pharmacy and Technology. 2018;11(11):4837-4841.
8. Johansen NJ, Christensen MB. A systematic review on insulin overdose cases: clinical course, complications and treatment options. Basic and clinical pharmacology and toxicology. 2018; 122(6):650-659.
9. Dereli FT, Ilhan M, Akkol EK. New drug discovery from medicinal plants and phytoconstituents for depressive disorders. CNS and Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS and Neurological Disorders). 2019; 18(2):92-102.
10. Abdelhalim A, Aburjai T, Hanrahan J, Abdel-Halim H. Medicinal plants used by traditional healers in Jordan, the Tafila region. Pharmacognosy magazine. 2017; 13(Suppl 1): S95.
11. Abascal K, Yarnell E. Using bitter melon to treat diabetes. Alternative and Complementary Therapies. 2005 Aug 1;11(4):179-184.
12. Ogbonna CI, Ogbonna AI, Itelima JU, Umar AF, Onyezili N, Istifanus MF. Combined Anti-diabetic Effects of Extracts of Artemisia annua var. chiknensis (CBGE/CHNA/09/LTNGS/G) and Each of Three other Plants (Momordica charantia Linn. Vernonia amygdalina Del. and Aegle marmelos Correa) Traditionally Used in Nigeria for the Treatment of Diabetes. 2017.
13. Kim YK, Xu H, Park NI, Boo HO, Lee SY, Park SU. Amino acid and GABA content in different cultivars of Momordica charantia L. Journal of Medicinal Plants Research. 2009 Nov 30;3(11):894-897.
14. Snee LS, Nerurkar VR, Dooley DA, Efird JT, Shovic AC, Nerurkar PV. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management. Nutrition journal. 2011 Dec 1;10(1):78.
15. Budrat P, Shotipruk A. Extraction of phenolic compounds from fruits of bitter melon (Momordica charantia) with subcritical water extraction and antioxidant activities of these extracts. Chiang Mai J. Sci. 2008 Jan 1;35(1):123-130.
16. Yibchok-Anun S, Adisakwattana S, Yao CY, Sangvanich P, Roengsumran S, Hsu WH. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biological and Pharmaceutical Bulletin. 2006;29(6):1126-1131.
17. Khurana SM, Kumar N. Phytochemistry and medicinal benefits of bitter gourd (Momordica charantia L.). International Journal of Innovative Hrticulture. 2017; 6(2):111-121.
18. Bolognesi A, Bortolotti M, Battelli M, Polito L. Hyperuricaemia, Xanthine Oxidoreductase and Ribosome‐Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research. Molecules. 2017; 22(2):206.
19. Srinivasan K, Ramarao P. Animal model in type 2 diabetes research: An overview. Indian Journal of Medical Research. 2007 Mar 1;125(3):451.
20. Sasaki T, Masty S, Sonae A. Effect of acetic acid concentration on the color reaction in the O-toluidine boric acid method for blood glucose estimation. Rinshbo Kagaku 1972; 1:346-353.
21. Lowry OH, Roseborough NJ, Farr AL, Randall RJ. Protein measurement with Folin’s phenol reagent. J Biol Chem 1951; 193:265-275.
22. Warnick, R.G., Alberts, J., 1978. A comprehensive evaluation of the heparin manganese precipitating procedure for estimating high-density lipoprotein cholesterol. J. Lipid Res. 119, 65–69.
23. Foster LB, Dunn RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clinical chemistry. 1973 Mar 1;19(3):338-40.
24. Brandstrup N, Kirk JE, Brunic C. Determination of glucokinase in tissues. J Gerontol 1957; 12:166–171.
25. Morales MA, Jabbay AJ, Tenenzi HP. Mutation affecting accumulation of glycogen. Neurospora. Newsl 1975; 20:24–25.
26. Sharma VK, Kumar S, Patel HJ, Hugar S. Hypoglycemic activity of Ficus glomerata in alloxan induced diabetic rats. International Journal of Pharmaceutical Sciences Review and Research. 2010;1(2):18-22.
27. Ghosh S, Suryawanshi SA. Effect of Vinca rosea extracts in treatment of alloxan diabetes in male albino rats. 2001.
28. Shirwaikar A, Rajendran K, Kumar CD, Bodla R. Antidiabetic activity of aqueous leaf extracts of Annona squamosa in streptozotocin– n3cotinamide type 2 diabetic rats. Journal of ethnopharmacology. 2004; 91(1):171-175.
29. Papazyan R, Liu X, Liu J, Dong B, Plummer EM, Lewis RD, Roth JD, Young MA. FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver. Journal of lipid research. 2018; 59(6):982-993.
30. Kalaivani K, Sankaranarayanan C. Modulatory effect of isopulegol on hepatic key enzymes of glucose metabolism in high-fat diet/streptozotocin- induced diabetic rats. Archives of physiology and biochemistry. 2019:1-9.
31. US MR, Sundaram CS, Srinivasan S. Gymnemic acid mitigates hyperglycemia by attenuating the hepatic glucose metabolic enzymes in high fat diet fed-low dose streptozotocin-induced experimental rodents. Research Journal of Pharmacy and Technology. 2020;13(2):719-726.
32. Prince M, Jarmin M, Lee K, Makadia F, Milgrom A, Rothschild M, Min S, Schlamm I, Mahida C, Duhon G, Wang P. CRT-600.08 Treatment Of Severe Hypertriglyceridemia (500-≥ 2000 Mg/dl) In 405 Patients. JACC: Cardiovascular Interventions. 2017; 10(3 Supplement): S54.
33. Sankaranarayanan C, Nishanthi R, Pugalendi P. Ameliorating effect of berbamine on hepatic key enzymes of carbohydrate metabolism in high-fat diet and streptozotocin induced type 2 diabetic rats. Biomedicine and Pharmacotherapy. 2018; 103:539-545.
34. Lucas EA, Dumancas GG, Smith BJ, Clarke SL, Arjmandi BH. Health benefits of bitter melon (Momordica charantia). InBioactive Foods in Promoting Health 2010 (pp. 525-549). Academic Press.
35. Chaithra Amin B, Satish S, Abhishek N, Ajay Kumar K. An investigation on anti-diabetic activity in aqueous extract of aerial parts of Allamanda cathartica Linn in streptozotocin induced diabetic rats. Int. J. Pharm. Chem. Res. 2017; 3:242-247.
36. Rao US, Yusoff HB. Unraveling the association of tobacco smoking (nicotine) with gut and adipocyte appetite regulator hormones-A systematic review. Research Journal of Pharmacy and Technology. 2019;12(2):913-919.
37. Bajaj S, Khan A. Antioxidants and diabetes. Indian journal of endocrinology and metabolism. 2012; 16(Suppl 2): S267.
38. Rao US. In Vitro Free Radical Scavenging and Reducing Potentials as well as Inhibitory Potential on α-Amylase and α-Glucosidase Activities of Fruit of Morinda citrifolia (Rubiaceae). Research Journal of Pharmacy and Technology. 2018;11(9):4135-4142.
39. Althunibat OY, Al-Mustafa AH, Tarawneh K, Khleifat KM, Ridzwan BH, Qaralleh HN. Protective role of Punica granatum L. peel extract against oxidative damage in experimental diabetic rats. Process Biochemistry. 2010; 45(4):581-585.
40. Gandhi GR, Sasikumar P. Antidiabetic effect of Merremia emarginata Burm. F. in streptozotocin induced diabetic rats. Asian Pacific journal of tropical biomedicine. 2012; 2(4):281-286.
41. Reyman TA. 13. Pathology of pancreatic transplants. Pancreas Transplantation. 2012:227.